Exactech, Inc. (EXAC) Shares Sold by Martingale Asset Management L P
Martingale Asset Management L P decreased its holdings in shares of Exactech, Inc. (NASDAQ:EXAC) by 41.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,721 shares of the medical equipment provider’s stock after selling 30,602 shares during the quarter. Martingale Asset Management L P’s holdings in Exactech were worth $2,113,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also modified their holdings of the company. Dimensional Fund Advisors LP grew its holdings in shares of Exactech by 5.6% during the third quarter. Dimensional Fund Advisors LP now owns 874,161 shares of the medical equipment provider’s stock valued at $28,803,000 after buying an additional 46,400 shares in the last quarter. Gamco Investors INC. ET AL grew its stake in Exactech by 24.8% in the fourth quarter. Gamco Investors INC. ET AL now owns 764,508 shares of the medical equipment provider’s stock valued at $37,805,000 after purchasing an additional 151,991 shares in the last quarter. Gabelli Funds LLC grew its stake in Exactech by 138.7% in the fourth quarter. Gabelli Funds LLC now owns 701,748 shares of the medical equipment provider’s stock valued at $34,701,000 after purchasing an additional 407,724 shares in the last quarter. Vanguard Group Inc. grew its stake in Exactech by 1.6% in the second quarter. Vanguard Group Inc. now owns 415,253 shares of the medical equipment provider’s stock valued at $12,375,000 after purchasing an additional 6,594 shares in the last quarter. Finally, Pentwater Capital Management LP purchased a new position in Exactech in the fourth quarter valued at about $12,363,000. Institutional investors and hedge funds own 61.22% of the company’s stock.
Exactech, Inc. (NASDAQ EXAC) opened at $49.25 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 4.08 and a quick ratio of 2.09. Exactech, Inc. has a 52 week low of $23.75 and a 52 week high of $50.95. The company has a market capitalization of $707.53, a PE ratio of 4,925.00, a price-to-earnings-growth ratio of 3.66 and a beta of 0.90.
WARNING: This news story was posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/exactech-inc-exac-shares-sold-by-martingale-asset-management-l-p/1907086.html.
Exactech Company Profile
Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.
Want to see what other hedge funds are holding EXAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exactech, Inc. (NASDAQ:EXAC).
Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.